Pratyush Porel

GT Road
Moga, PB 142001, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

cGAS-STING as a Neuroimmune Traffic Molecule: Unraveling Pathogenic Mechanisms and Therapeutic Potential in Neurological Disorders.

cGAS-STING as a Neuroimmune Traffic Molecule: Unraveling Pathogenic Mechanisms and Therapeutic Potential in Neurological Disorders.

Journal: Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology

Published: February 24, 2026

Unknotting the Role of circRNAs and IGF2BP3 in Alzheimer's Disease.

Unknotting the Role of circRNAs and IGF2BP3 in Alzheimer's Disease.

Journal: Cellular and molecular neurobiology

Published: February 15, 2026

Decoding Neuroinflammatory Pathways: The Role of the CXCL12-CXCR4/CXCR7 Axis in ALS-Related Cognitive Impairment.

Decoding Neuroinflammatory Pathways: The Role of the CXCL12-CXCR4/CXCR7 Axis in ALS-Related Cognitive Impairment.

Journal: Molecular neurobiology

Published: December 26, 2025

Smart sensing the spectrum: cutting-edge biosensor and biomarker approaches for early autism detection.

Smart sensing the spectrum: cutting-edge biosensor and biomarker approaches for early autism detection.

Journal: Metabolic brain disease

Published: December 06, 2025

RLIP76: a versatile ATP-dependent transporter as a pharmacotherapeutic target for epilepsy management.

RLIP76: a versatile ATP-dependent transporter as a pharmacotherapeutic target for epilepsy management.

Journal: Inflammopharmacology

Published: October 11, 2025

Galectin-3 as a Key Driver of Neuroinflammation and α-Synuclein Aggregation in Parkinson's Disease: Unlocking New Paths for Biomarkers and Therapies.

Galectin-3 as a Key Driver of Neuroinflammation and α-Synuclein Aggregation in Parkinson's Disease: Unlocking New Paths for Biomarkers and Therapies.

Journal: Cell biochemistry and biophysics

Published: August 23, 2025

Galectin-3 in Alzheimer's disease: pathological roles, biomarker potential, and therapeutic implications.

Galectin-3 in Alzheimer's disease: pathological roles, biomarker potential, and therapeutic implications.

Journal: Brain research

Published: April 07, 2025

Unraveling the role of CGRP in neurological diseases: a comprehensive exploration to pathological mechanisms and therapeutic implications.

Unraveling the role of CGRP in neurological diseases: a comprehensive exploration to pathological mechanisms and therapeutic implications.

Journal: Molecular biology reports

Published: March 11, 2025

Transthyretin as a therapeutic target: the future of disease-modifying therapies for Alzheimer's disease.

Transthyretin as a therapeutic target: the future of disease-modifying therapies for Alzheimer's disease.

Journal: Molecular biology reports

Published: March 02, 2025

Emerging biomarkers for pancreatic cancer: from early detection to personalized therapy.

Emerging biomarkers for pancreatic cancer: from early detection to personalized therapy.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: February 26, 2025

Is the renin-angiotensin system a friend or foe in neurological diseases? Unveiling its role and therapeutic potential.

Is the renin-angiotensin system a friend or foe in neurological diseases? Unveiling its role and therapeutic potential.

Journal: Ageing research reviews

Published: February 26, 2025

Unlocking the neuroprotective potential of peptide nucleic acids 5 (PNA5) in neurological diseases: molecular mechanisms to therapeutic approaches.

Unlocking the neuroprotective potential of peptide nucleic acids 5 (PNA5) in neurological diseases: molecular mechanisms to therapeutic approaches.

Journal: Metabolic brain disease

Published: February 07, 2025

Showing 1-12 of 18

Last Updated: 09/26/2026